HemaSphere
(Aug 2023)
PB1761: PRECLINICAL EVALUATION OF THE MENIN INHIBITOR ZIFTOMENIB IN PRIMARY AML SPECIMENS
- Brett Stevens,
- Krysta Engel,
- Austin Gillen,
- Shanshan Pei,
- Anna Krug,
- Monica Ransom,
- Sarah Staggs,
- Francis Burrows,
- Blake Tomkinson,
- Linda Kessler,
- Craig Jordan,
- Clayton Smith
Affiliations
- Brett Stevens
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Krysta Engel
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Austin Gillen
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Shanshan Pei
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Anna Krug
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Monica Ransom
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Sarah Staggs
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Francis Burrows
- 2 Kura Oncology, Inc., San Diego, United States
- Blake Tomkinson
- 2 Kura Oncology, Inc., San Diego, United States
- Linda Kessler
- 2 Kura Oncology, Inc., San Diego, United States
- Craig Jordan
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Clayton Smith
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- DOI
-
https://doi.org/10.1097/01.HS9.0000973900.20086.99
- Journal volume & issue
-
Vol. 7
p.
e2008699
WeChat QR code